All articles starting with H
20,046 articles
HRP-4C
HRP-4C is a feminine humanoid robot developed by Japan's AIST and unveiled in 2009, known publicly as a catwalk model, master of ceremonies, and singer named Miim.
HRP-5P
HRP-5P is a life-sized humanoid robot prototype developed by Japan's National Institute of Advanced Industrial Science and Technology, announced in 2018 to perform heavy labor autonomously.
HRS-1167 (PARP1 inhibitor)
HRS-1167 (M9466) is Jiangsu Hengrui's oral, second-generation selective PARP1 inhibitor with DNA trapping activity, licensed to Merck KGaA in 2023 for EUR160 million and later discontinued by Merck; distinct from Merck & Co's MK-1167 Alzheimer's drug.
HRS-1596
HRS-1596 (Hengrui Pharma) is a phase 1-ready oral GLP-1R/GIPR dual agonist for once-weekly dosing in obesity and type 2 diabetes, licensed to Novo Nordisk on 29 September 2026 for up to $2.6 billion excluding Greater China.
HRS-4729
HRS-4729 (KAI-4729) is Hengrui's once-weekly injectable GLP-1/GIP/glucagon tri-agonist peptide for obesity, licensed to Kailera outside Greater China; its Phase 1 trial showed 16.0% weight loss at 12 weeks.
HRS-5346
HRS-5346 (MK-7262) is Hengrui's oral small-molecule lipoprotein(a) inhibitor, licensed to MSD outside Greater China for $200 million upfront; Phase 2 in China cut Lp(a) up to 86% at 12 weeks.
HRS-7249
HRS-7249: GalNAc-conjugated APOC3-targeting siRNA injection by Hengrui's Shanghai Tuojie unit, in phase 2 China trials for hyperlipidemia and severe hypertriglyceridemia; phase 1 TG cuts of 62-75%.
HRS-7535
HRS-7535 is Jiangsu Hengrui's once-daily oral small-molecule (nonpeptide) GLP-1 receptor agonist for type 2 diabetes and weight management; phase 2 trials showed HbA1c cuts up to 1.57% and weight loss up to 9.36%, with a China NDA accepted in 2026.
HRS-9821, PDE3/PDE4 dual inhibitor (COPD)
HRS-9821 (GSK-licensed Hengrui compound) is an investigational inhaled dual PDE3/PDE4 inhibitor for COPD add-on maintenance therapy, in phase II trials in China and licensed to GSK worldwide ex-Greater China in July 2025.
HRS9531 (瑞普泊肽)
HRS9531 (瑞普泊肽, ribupatide, KAI-9531) is Jiangsu Hengrui's once-weekly dual GLP-1/GIP receptor agonist for obesity and type 2 diabetes; phase 3 showed 19.2% weight loss at 48 weeks, with NDAs filed in China.
HRT 2
HRT 2 is the shared name of two national public channels of Croatian Radiotelevision (HRT): HTV 2, the second TV channel launched permanently in 1972, and HR 2, the second radio program started in April 1964, both Zagreb-based and Croatian-language.
Hrvatska elektroprivreda
Hrvatska elektroprivreda (HEP) is the Croatian state-owned electric power company established on 28 July 1990, which generates, transmits, and distributes electricity, supplies heat and gas, and co-owns the Krško nuclear plant in Slovenia.
Hrvatske željeznice
Hrvatske željeznice (Croatian Railways, abbreviated HŽ) is the national railway system of Croatia, formed in 1991 and split in 2006 into companies managing the 2,617 km network, passenger trains, and freight.
Hrvatski olimpijski odbor
Hrvatski olimpijski odbor (Croatian Olympic Committee, HOO) is Croatia's national Olympic committee, founded 10 September 1991, IOC-recognized 1992–1993, the country's roof sports association with 113 members, based in Zagreb.
Hrvatski Telekom
Hrvatski Telekom, formerly HT – Hrvatske telekomunikacije, is Croatia's largest telecommunications company, headquartered in Zagreb, majority owned by Deutsche Telekom and traded on the Zagreb Stock Exchange.
Hrvoje Horvat
Hrvoje Horvat (Cveba), born 1946 in Bjelovar, Croatian handball player and coach; Olympic gold 1972 with Yugoslavia, 231 caps, European Champions Cup with Partizan. Also his son Hrvoje Horvat Jr. (born 1977), Croatia national coach 2021–2023.
Hrvoje Petek
Hrvoje Petek is a physicist at the University of Pittsburgh who studies ultrafast electron and plasmon dynamics at surfaces, imaging them on femtosecond and attosecond scales and winning the 2019 Ahmed Zewail Award.
Hrvoje Vukčić Hrvatinić
Hrvoje Vukčić Hrvatinić was a Bosnian magnate and Grand Duke of Bosnia who dominated Bosnia and Dalmatia from the 1380s until his death in 1416.
Hrvy
HRVY is the stage name of Harvey Leigh Cantwell (born 1999), British pop/R&B singer from Kent; not the tech-house producer Hrvy (H) or Hrvy Dent. Known for "Personal", "Hasta Luego" with Malu Trevejo, Strictly Come Dancing 2020, and the shelved album Can Anybody Hear Me?.
Hryhor Orlyk
Hryhor Orlyk (Григор Орлик, 1702–1759) was a Ukrainian émigré leader who served Louis XV as a diplomat and French lieutenant general, seeking support for Cossack self-rule in Ukraine.
Hryhorii Hrabianka
Hryhorii Hrabianka (Григорій Граб'янка) was a Cossack officer who rose to colonel of the Hadiach regiment and wrote a 1710 chronicle of Ukraine centered on the Khmelnytsky uprising.
Hryhorii Kvitka-Osnovianenko
Hryhorii Kvitka-Osnovianenko (Григорій Квітка-Основ'яненко, 1778–1843) was a Ukrainian writer and playwright, known as the father of Ukrainian prose and a founder of Kharkiv's cultural life.
Hryhoriy Misiutin
Hryhoriy Misiutin (Григорій Анатолійович Місютін), Ukrainian artistic gymnast born 1970 in Oleksandriya; 1992 Olympic team gold for the Unified Team, 1991 world all-around champion, six Olympic medals total, retired 1996, lives in Germany.
Hs 294T
Hs 294T (HS294T, CVCL_0331, ATCC HTB-140) is a human metastatic melanoma cell line from a lymph node metastasis, BRAF V600E and TERT promoter mutant, used in drug-response and resistance research.
Hs 578T
Hs 578T (ATCC HTB-126, CVCL_0332) is a human triple-negative, basal-like breast cancer cell line derived in 1977 from a 74-year-old patient, syngeneic with Hs 578Bst, carrying an H-ras codon 12 mutation and a hypotriploid karyotype.
Hs 675.T
Hs 675.T (Hs675T, CVCL_0836, ATCC CRL-7400) is a human colon-derived fibroblast cell line, male Caucasian donor, originally misclassified as colorectal carcinoma; doubling time 6-7 days, DMEM culture, documented STR profile.
Hs 700T
Hs 700T (HS700T, CVCL_0858, ATCC HTB-147) is a human pancreatic ductal adenocarcinoma cell line from a 61-year-old man's pelvic metastasis, hypertetraploid, TP53 p.Arg249Met, doubling time 4-5 days.
Hs 746.T
Hs 746.T (Hs746T, CVCL_0333, ATCC HTB-135) is a human diffuse-type gastric adenocarcinoma cell line established in 1973 from a skeletal muscle metastasis, MET-amplified with a c-Met exon 14 splice mutation, used in MET-inhibitor drug testing.
Hs 766T
Hs 766T (Hs-766T, HS766T, CVCL_0334, ATCC HTB-134) is a human pancreatic adenocarcinoma cell line isolated in 1973 from a lymph node metastasis, carrying homozygous KRAS Q61H and SMAD4 deletion, gemcitabine-resistant, with a normoid gene expression profile.
HS Produkt Kuna
The HS Produkt Kuna is a compact Croatian submachine gun in 9×19 mm and .40 S&W, launched in the United States by Springfield Armory in 2025.